BioSpace News Archive

Business

BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2021 on Wednesday, March 30th, 2022.

March 16, 2022
·
2 min read
Business

PharmaCyte Biotech Reports Third Quarter Financial Results and Operational Highlights

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today the financial and operational results for its third quarter ended January 31, 2022.

March 16, 2022
·
6 min read
Hemogenyx Pharmaceuticals PLC Announces CBR Update.

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that it has achieved proof of concept for its Chimeric Bait Receptor platform technology.

March 16, 2022
·
5 min read
Pharm Country

KaliVir Immunotherapeutics Closes Series A Financing

KaliVir Immunotherapeutics, Inc., a privately held biotechnology company focused on the discovery and development of leading-edge oncolytic vaccinia virus immunotherapies, announced the closing of its Series A financing.

March 16, 2022
·
3 min read
BioMidwest

Monteris Medical Announces Study Published on Patient Preferences for Drug-Resistant Epilepsy Treatment Options

Monteris Medical announced today that a study on patient preferences for treating drug-resistant epilepsy (DRE) has been published in the peer-reviewed journal, Epilepsy and Behavior.

March 16, 2022
·
3 min read
Genetown

Curiox Biosystems Closes $15 million Funding Round to Expedite Worldwide Adoption of Next-Generation Cell Prep Technology

Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round.

March 16, 2022
·
4 min read
Lone Star Bio

Roelof Botha, Lead Independent Director of Natera Board, Makes $5 Million Investment in Natera

Natera, Inc., a global leader in cell-free DNA testing, announced that Roelof Botha, lead independent director of Natera’s board of directors and partner at Sequoia Capital, has invested $5 million to purchase shares of Natera’s stock on the open market.

March 16, 2022
·
2 min read
Cognitive Function Test for Normal Subjects Developed in Japan, an Advanced Super-Aging Nation, Article Published in International Medical Journal (Dementia and Geriatric Cognitive Disorders)

Developed by Research Institute of Brain Activation and the Tokyo Metropolitan Institute of Technology, Brain Assessment is an online cognitive function test for healthy individuals that compares the average rate of cognitive decline with aging.

March 16, 2022
·
2 min read
Cancer Immunotherapy Market to Garner Growth 12.6% by 2030

According to Report, the cancer immunotherapy market is expected to grow at a notable CAGR of 12.6% over forecast period 2021 to 2030 and to reach over US$ 277.1 billion by 2030.

March 16, 2022
·
4 min read
3D (Three-Dimensional) Imaging Market Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2030

Rising demand for consumer electronics and increasing preference for high-resolution images in gaming industry are driving three-dimensional (3D) imaging market revenue growth.

March 16, 2022
·
8 min read